Indexperts Gorilla激进成长主动型ETF RILA 深 沪
已收盘 05-22 16:00:00 美东时间
11.7612
+0.107
+0.91%
华盛通- 最 高11.79
- 今 开11.78
- 成交量 7159股
- 最 低 11.7612
- 昨 收 11.6546
- 总市值 4359.90万
- 52周最高 12.1292
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 10.06
- 委 比 0.00%
- 总股本 370.70万
- 历史最高 12.1292
- 量 比 8.38
- 振 幅 0.25%
- 历史最低 8.6072
- 每 手 1
- 风险率 0.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jackson targets $1.2B 2026 free capital generation while maintaining $900M-$1.1B capital return
Earnings Call Insights: Jackson Financial (JXN) Q1 2026 Management View CEO Laura Prieskorn said “2026 is off to a strong start” and highlighted “total adjusted capital of $5.5 billion” and a “$288 mi...
05-07 00:22
Prudential Financial Q1 2026 Earnings Call Transcript
Prudential Financial (NYSE:PRU) held its first-quarter earnings conference call...
05-07 00:11
Athene Rolls Out Athene Amplify 3.0 Annuity
Athene, the leading retirement solutions company and subsidiary of Apollo Global Management (NYSE:APO), today announced the launch of Athene Amplify 3.0, a registered index-linked annuity (RILA) designed to expand
05-04 19:48
Jackson Financial Q4 adjusted operating earnings rise
Jackson Financial Q4 adjusted operating earnings rise Overview Annuity provider's Q4 adjusted operating earnings rose, driven by higher spread income Company reported record Q4 retail annuity sales, up 27% yr/yr Company returned $205 mln to shareholders in Q4 through repurchases and dividends Outloo
02-19 05:23
Jackson JXN posts Q4 retail annuity sales of USD 5.9B (+27%)
Jackson JXN posts Q4 retail annuity sales of USD 5.9B (+27%) Jackson (JXN) reported Q4 2025 net loss attributable to common shareholders of USD 215 million (USD -3.13 per diluted share) and adjusted operating earnings of USD 455 million (USD 6.61 per diluted share). Retail annuity sales in Q4 were a
02-19 05:18
The $461B Boom That Advisors Can't Ignore
Stock market up, tech and AI lead. Annuities shatter records for 4th year, driven by demand for guarantees in volatile market. Boomers and Gen X interested.
02-16 00:01
Corebridge meldet für das Gesamtjahr 2025 eine Kapitalrückführung an Aktionäre von 2,6 Mrd. USD, ein Plus von 13 Prozent
Corebridge meldet für das Gesamtjahr 2025 eine Kapitalrückführung an Aktionäre von 2,6 Mrd. USD, ein Plus von 13 Prozent Corebridge Financial meldet für das Gesamtjahr 2025 einen operativen Gewinn je Aktie von USD 4,42, was einem Anstieg von 4 Prozent gegenüber dem Vorjahr entspricht. Die bereinigte
02-10 05:16
Corebridge Financial Q4 net flows drop 62% to USD 641 million
Corebridge Financial Q4 net flows drop 62% to USD 641 million Corebridge Financial reported its fourth quarter (Q4) and full year (FY) 2025 results, posting an operating EPS of 4.42 for FY 2025, up 4% year over year (YoY). Adjusted ROAE reached 11.5%, an increase of 0.2 percentage points YoY. The co
02-10 05:16
BRIEF-Reviva Announces Regulatory Update Regarding The Development Of Brilaroxazine For The Treatment Of Schizophrenia
Dec 23 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA ANNOUNCES REGULATORY UPDATE REGARDING THE DEVELOPMENT OF BRILAROXAZINE FOR THE TREATMENT OF SCHIZOPHRENIA REVIVA PHARMACEUTICALS H...
2025-12-23 21:19
BRIEF-Reviva Pharmaceuticals Recover-2 Trial Projected To Cost About $60 Million
Dec 23 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA PHARMACEUTICALS: RECOVER-2 TRIAL PROJECTED TO COST ABOUT $60 MILLION REVIVA PHARMACEUTICALS: MAY INITIATE PHASE 3 TRIAL OF BRILARO...
2025-12-23 21:10
